LAEVOLAC

This brand name is authorized in Austria, France, Ireland, Israel, New Zealand, Turkey.

Active ingredients

The drug LAEVOLAC contains one active pharmaceutical ingredient (API):

1	Lactulose UNII 9U7D5QH5AE - LACTULOSE
	Lactulose is a synthetic disaccharide which is metabolised by gastro-intestinal bacterial flora to low molecular weight acids (chiefly lactic and acetic acids). There is no endogenous metabolising enzyme in the human gut. Its mode of action in constipation is as an osmotic agent producing soft stools.
	Read more about Lactulose

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LAEVOLAC Oral solution	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A06AD11	Lactulose	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AD Osmotically acting laxatives
Discover more medicines within A06AD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	67423559
IL	מִשְׂרַד הַבְּרִיאוּת	5177, 5178
NZ	Medicines and Medical Devices Safety Authority	3806
TR	İlaç ve Tıbbi Cihaz Kurumu	8699508570058, 8699508570065